Dansylated analogues of the opioid peptide [Dmt1]DALDA: In vitro activity profiles and fluorescence parameters

10Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Dansylated analogues of the potent and selective μ opioid peptide agonist [Dmt1]DALDA (H-Dmt-D-Arg-Phe-Lys-NH2; Dmt = 2′,6′-dimethyltyrosine) were prepared either by substitution of Nβ-dansyl-α,β-diaminopropionic acid or N ε-dansyllysine for Lys4, or by attachment of a dansyl group to the C-terminal carboxamide function via a linker. All three analogues displayed high μ agonist potency in vitro and the C-terminally dansylated one retained significant μ receptor selectivity. The three analogues showed interesting differences in their fluorescence emission maxima and quantum yields, indicating that the dansyl group in two of them was engaged in intramolecular hydrophobic interactions. These dansylated [Dmt1]DALDA analogues represent valuable tools for binding studies, cellular uptake and intracellular distribution studies, and tissue distribution studies.

Cite

CITATION STYLE

APA

Berezowska, I., Lemieux, C., Chung, N. N., Zelent, B., & Schiller, P. W. (2004). Dansylated analogues of the opioid peptide [Dmt1]DALDA: In vitro activity profiles and fluorescence parameters. In Acta Biochimica Polonica (Vol. 51, pp. 107–113). Acta Biochimica Polonica. https://doi.org/10.18388/abp.2004_3601

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free